1 F. Charles Brunicardi, Dana K. Andersen, Timothy R. Billiar, David L. Dunn, John G.

Hunter, Lillian S. Kao, Jeffrey B. Matthews, Raphael E. Pollock, Schwartz’s Principles

of Surgery Eleventh Edition. New york. McGraw Hill: 2019

2. Klaus Wolf, Lowell A, Stephen Katz, Barbara A, Amy S, David J. Fitzpatrick’s

Dermatology in General Medicine Seventh Edition. New York. McGraw Hill: 2008

3. Klaus Wolff, Richard Allen Johnson. FITZPATRICK’S COLOR ATLAS AND

SYNOPSIS OF CLINICAL DERMATOLOGY SIXTH EDITION. New york. McGraw
Hill: 2009.

4. Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saiag, Mark Middleton, Lars
Bastholt , Jean-Jacques Grob, Josep Malvehy, Julia Newton-Bishop, Alexander J.
Stratigos, Hubert Pehamberger, Alexander M. Eggermon. Diagnosis and treatment of
melanoma. Center for Dermatooncology, University Department of Dermatology,
Liebermeisterstr.: European Journal of Cancer. 2016.

5. Piotr Rutkowski, Ewa Kalinka, Jacek Fijuth, Milena Szacht. Cutaneous melanoma -
Guidelines for diagnostics and therapy in 2016. DOI: 10.5114/dr.2016.57736.

6. GIULIA C. LEONARDI1, LUCA FALZONE, ROSSELLA SALEMI, ANTONINO

ZANGHÌ, DEMETRIOS A. SPANDIDOS, JAMES A. McCUBREY, SAVERIO
CANDIDO1 and MASSIMO LIBRA.. Cutaneous melanoma: From pathogenesis to
therapy (Review). Department of Biomedical and Biotechnological Sciences, Pathology and Oncology

Section, University of Catania. 2018.

7. Kevin Yang 1, Allen S.W. Oak 1, Radomir M. Slominski 2, Anna A. Bro˙zyna 3 and
Andrzej T. Slominski. Current Molecular Markers of Melanoma and Treatment
Targets. International Journal of Molecular Sciences. 2020.

8. Adina L. Milac, Gabriela Negroiu. The Multiple Roles of Tyrosinase-Related Protein-

2/LDopachrome Tautomerase in Melanoma: Biomarker,Therapeutic Target, and
Molecular Driver in Tumor Progression. Intech Open: 2018.
http://dx.doi.org/10.5772/intechopen.70513
9. Made Putri Hendaria, AAGN Asmarajaya, Sri Maliawan, Kanker kulit. Bagian/SMF
Ilmu Bedah Fakultas Kedokteran Universitas Udayana/Rumah Sakit Umum Pusat
Sanglah Denpasar. 2015

10 Eshini Perera, Rodney Daniel Sinclair, Neiraja Gnaneswaran. Malignant Melanoma.

University of Melbourne. 2013. DOI: 10.3390/healthcare2010001.

11. Paramartha, G.N.A.A., Niryana, I.W., Adiputra, P.A.T. 2019. Karakteristik Pasien
Melanoma Maligna di Subbagian Bedah Onkologi RSUP Sanglah Tahun 2015-2016.
Intisari Sains Medis 10(2): 197-200. DOI: 10.15562/ism.v10i2.242.

12 Mosqueira JR, Gomez E, Bravo F, Vega JD, Soto L. Malignant Melanoma: Case
Report and Review of the Literature. Open Access J Trans Med Res 1(2): 00008. DOI:
10.15406/oajtmr.2017.01.00008. 2017

13 Franki Lambert Smith, MD, Joshua Wisell, MD, and Mariah Brown, MD, Aurora,
Colorado. Advanced acral melanoma. Department of Dermatology, University of
Colorado. American Academy of Dermatology. 2015.

16 J.R. Marsden, J.A. Newton Bishop,L. Burrows, M. Cook, P.G. Corrie, N.H. Cox, M.E.
Gore, P.Lorigan, R. MacKie, P. Nathan, H. Peach, B. Powell and C. Walker. Revised
U.K. guidelines for the management of cutaneous melanoma 2010. British Journal of
Dermatology. 2010. DOI 10.1111/j.1365-2133.2010.09883.x

17. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical
Practice Guidelines for the Management of Melanoma in Australia and New Zealand.
Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand
Guidelines Group, Wellington. 2008.

19 Beatriz Domingues, José Manuel Lopes, Paula Soares, Helena Pópulo. Melanoma
treatment in review.Institute of Molecular Pathology and Immunology, University of
Porto (IPATIMUP). Dovepress: 2018.
20. Liborija Lugovic-Mihic, Gaby Novak Bilić, Diana Ćesić, Mirna Situm. Melanoma
Development: Current Knowledge on Melanoma Pathogenesis. University Department
of Dermatovenerology Sestre milosrdnice University Hospital Center. Acta
Dermatovenerol Croat. 2019.

23 M. Majem, J. L. Manzano, I. Marquez-Rodas, K. Mujika, E. Munoz-Couselo, E.

Perez-Ruiz, L. de la Cruz-Merino, E. Espinosa, M. Gonzalez-Cao, A. Berrocal. SEOM
clinical guideline for the management of cutaneous melanoma (2020). Clinical and
Translational Oncology. Springer. 2020

24. Justine Seuradge and Eric Wong. Melanoma. McMasterPathophisiology Review. 2018

25 Rodrigo Arrangoiz, Joel Dorantes, Fernando Cordera, Manuel Munoz Juarez, Eduardo
Moreno Paquentin, Enrique Luque de Leon. Melanoma Review: Epidemiology, Risk
Factors, Diagnosis and Staging. Journal of Cancer Treatment and Research. Vol. 4,
No. 1, 2016, pp. 1-15. doi: 10.11648/j.jctr.20160401.11

26. Fiona M Walter, A Toby Prevost, Joana Vasconcelos, Per N Hall, Nigel P Burrows,
Helen C Morris, Ann Louise Kinmonth and Jon D Emery. Using the 7-point checklist
as a diagnostic aid for pigmented skin lesions in general practice. British Journal of
General Practice. 2013

27. Jonathan B. Heistein; Utkarsh Acharya. Malignant Melanoma. NCBI StatPearls

Publishing LLC. 2021

28. Erin M. Wolf Horrell, Kalin Wilson, John A. D’Orazio. Melanoma — Epidemiology,
Risk Factors, and the Role of Adaptive Pigmentation. Intech. 2015.
http://dx.doi.org/10.5772/58994

1. Klaus wolff, Richard Allen. Fitzpatrick’s: Color Atlas and Synopsis of Clinical
Dermatology Sixth Edition. New york. McGraw Hill: 2009 p: 787-791.
2. Dermapath Diagnostics, Primary care Diagnostic institute. Verruca Vulgaris.
WWW.dermapathdiagnostics.com (Dikunjungi 19-01-2018). p: 1